Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results

Author's Avatar
Mar 29, 2023

Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory Diseases